Abstract
Human placental ferritin is an immunosuppressive protein composed of a 43-kDa subunit (p43) and ferritin light chains. Its physiological action seems to be downregulation of the immune response of the mother against her embryo. Elevated levels of p43 in serum are associated with pregnancy, lymphomas, breast cancer, and AIDS. Although it is known that p43 is produced by activated T lymphocytes, the specific T-lymphocyte subset involved is unknown. p43 is measured by enzyme-linked immunosorbent assays with CM-H-9 monoclonal antibody specific for p43. We studied the de novo biosynthesis of p43 by isolated activated CD4+ and CD8+ T lymphocytes in a normal donor and in a patient with elevated levels of p43 in serum. The results indicated that p43 was synthesized by activated CD4+ lymphocytes from the normal donor (0.45% of the total de novo proteins) but that its biosynthesis by CD8+ lymphocytes was below the level of detection. The activated CD4+ lymphocytes from the patient with elevated levels of p43 in serum overproduced p43 (3.8% of the nascent proteins). Since it was shown that a subset of CD8+ lymphocytes has receptors for p43, the latter may be considered an immunoregulatory cytokine produced mainly by activated CD4+ lymphocytes.
Full Text
The Full Text of this article is available as a PDF (153.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dinari G., Zahavi I., Marcus H., Moroz C. Placental ferritin in coeliac disease: relation to clinical stage, origin, and possible role in the pathogenesis of malignancy. Gut. 1991 Sep;32(9):999–1003. doi: 10.1136/gut.32.9.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fargion S., Fracanzani A. L., Brando B., Arosio P., Levi S., Fiorelli G. Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood. 1991 Aug 15;78(4):1056–1061. [PubMed] [Google Scholar]
- Hann H. W., Stahlhut M. W., Chung L. C. Inhibitory effects of isoferritins from tumour and non-tumour tissues on E-rosette formation. Lancet. 1984 Jan 7;1(8367):43–43. doi: 10.1016/s0140-6736(84)90201-0. [DOI] [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Moroz C., Bessler H., Lurie Y., Shaklai M. New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies. Exp Hematol. 1987 Mar;15(3):258–262. [PubMed] [Google Scholar]
- Moroz C., Kupfer B., Twig S., Parhami-Seren B. Preparation and characterization of monoclonal antibodies specific to placenta ferritin. Clin Chim Acta. 1985 May 30;148(2):111–118. doi: 10.1016/0009-8981(85)90220-7. [DOI] [PubMed] [Google Scholar]
- Moroz C., Misrock S. L., Siegal F. P. Isoferritins in HIV infection: relation to clinical stage, CD8 lymphocyte binding and the pathogenesis of AIDS. AIDS. 1989 Jan;3(1):11–16. [PubMed] [Google Scholar]
- Moroz C., Shterman N., Kupfer B., Ginzburg I. T-cell mitogenesis stimulates the synthesis of a mRNA species coding for a 43-kDa peptide reactive with CM-H-9, a monoclonal antibody specific for placental isoferritin. Proc Natl Acad Sci U S A. 1989 May;86(9):3282–3285. doi: 10.1073/pnas.86.9.3282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Novogrodsky A., Katchalski E. Induction of lymphocyte transformation by sequential treatment with neuraminidase and galactose oxidase. Proc Natl Acad Sci U S A. 1973 Jun;70(6):1824–1827. doi: 10.1073/pnas.70.6.1824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosen H. R., Moroz C., Reiner A., Stierer M., Svec J., Reinerova M., Schemper M., Jakesz R. Expression of p43 in breast cancer tissue, correlation with prognostic parameters. Cancer Lett. 1992 Oct 30;67(1):35–45. doi: 10.1016/0304-3835(92)90006-h. [DOI] [PubMed] [Google Scholar]
- Sirota L., Kupfer B., Moroz C. Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy. Clin Exp Immunol. 1989 Aug;77(2):257–262. [PMC free article] [PubMed] [Google Scholar]